Anti-CD4 mAb-Fragment
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-CD4 mAb-Fragment, covering 2012-02-03 to 2012-02-03. Get the full timeline:
Most recent: Clinical Trial Update: The Use of Anti-CD4 mAb-Fragment for Imaging of Local Inflammation in Patients With Carotid Artery Stenosis [Phase 2]